
浏览全部资源
扫码关注微信
纸质出版:2016
移动端阅览
张荣华,闫国和,汪国建,粟永萍.鳖甲煎改良方含药血清对肝星状细胞增殖、周期及凋亡的影响[J].陆军军医大学学报(原第三军医大学学报),2016,38(08):905-910.
Zhang Ronghua,Yan Guohe,Wang Guojian,Su Yongping.Effect of serum containing modified turtle shell decoction on proliferation, cell cycle and apoptosis of hepatic stellate cell line T6[J].J Amry Med Univ (J Third Mil Med Univ),2016,38(08):905-910.
张荣华,闫国和,汪国建,粟永萍.鳖甲煎改良方含药血清对肝星状细胞增殖、周期及凋亡的影响[J].陆军军医大学学报(原第三军医大学学报),2016,38(08):905-910. DOI:
Zhang Ronghua,Yan Guohe,Wang Guojian,Su Yongping.Effect of serum containing modified turtle shell decoction on proliferation, cell cycle and apoptosis of hepatic stellate cell line T6[J].J Amry Med Univ (J Third Mil Med Univ),2016,38(08):905-910. DOI:
目的 探讨鳖甲煎改良方含药血清对大鼠肝星状细胞(hepatic stellate cell,HSC)-T6增殖、周期及凋亡的影响。 方法 分别用高剂量[28.4 g/(kg·d)]、中剂量[14.2 g/(kg·d)]与低剂量[7.1 g/(kg·d)]的鳖甲煎改良方及与鳖甲煎改良方高剂量相同剂量的鳖甲煎丸灌胃大鼠以制备含药血清。将等体积不同剂量的鳖甲煎改良方含药血清分别处理HSC-T6细胞,以等体积鳖甲煎丸含药血清处理的细胞为阳性对照组,生理盐水处理的细胞为空白对照组,正常大鼠血清处理的细胞为正常对照组。CCK-8检测不同处理组HSC-T6细胞的增殖情况,并绘制其增殖曲线;流式细胞仪(flow cytometry
FCM)检测经不同处理的HSC-T6细胞的周期,Annexin V-PI染色法检测其凋亡;在mRNA及蛋白水平分别检测经不同处理的HSC-T6细胞的增殖细胞核抗原(proliferating cell nuclear antigen,PCNA)基因及其编码蛋白的表达变化。 结果 CCK-8检测结果显示,鳖甲煎改良方含药血清对HSC-T6细胞增殖具抑制作用,高剂量与中剂量组的增殖速度慢于正常对照组、阳性对照组和空白对照组(P0.05,P0.01),且该抑制作用呈剂量-效应关系。FCM检测证实,鳖甲煎改良方含药血清可将HSC-T6细胞阻滞于S期,能诱导HSC-T6细胞的凋亡,与正常对照组比较,其凋亡诱导率差异具有统计学意义(P0.01)。mRNA与蛋白水平检测结果显示,与空白对照组和阳性对照组比较,高剂量组能在基因与蛋白水平显著下调HSC-T6细胞PCNA的表达。 结论 鳖甲煎改良方含药血清能明显抑制HSC-T6细胞的增殖,诱导HSC-T6细胞的凋亡,并能下调其PCNA基因及其编码蛋白的表达。
Objective To explore the effect of serum containing modified turtle shell decoction (MTSD) on the proliferation
cell cycle and apoptosis of hepatic stellate cell line T6 (HSC-T6). Methods Serum containing MTSD or turtle shell pills (TSP) was prepared
and the rats were treated with MTSD at 28.4 g/(kg·d) as a high-dose group
at 14.2 g/(kg·d) as a medium-dose group
at 7.1 g/(kg·d) as a low-dose group or with TSP at 9.0 g/(kg·d) as a control group by intragastric administration. HSC-T6 cells were treated with serum containing different doses of MTSD in equal to volume. The same cells were treated with serum containing TSP as a positive control
treated with normal salt solution as a blank control
and treated with normal rat serum in equal to volume as a normal control. The proliferation of HSC-T6 cells in different groups were tested by cell count kit-8 (CCK-8) assay
and the proliferation curves were draw. Cell cycle of HSC-T6 cells was tested by flow cytometry (FCM). Annexin V-PI was applied to analyze the apoptosis of the cells. The gene and protein expressions of proliferating cell nuclear antigen (PCNA) of HSC-T6 cells were detected with RT-PCR and Western blot
respectively. Results The results of CCK-8 assay revealed that serum containing MTSD could prevent HSC-T6 cells from proliferation with a dose-effect relationship. The proliferation of the HSC-T6 cells treated with high-dose or middle-dose serum containing MTSD was lower than that of the controls
and the differences were statistically significant after the cells were treated for 48 h (P0.05
P0.01
respectively). Serum containing MTSD affected the cell cycle of HSC-T6 cells
and blocked the cells at S stage. Serum containing MTSD could significantly induce apoptosis of HSC-T6 cells compared with the controls (P0.01). The results of RT-PCR
Western blot and quantitative analyses indicated that the high-dose or middle-dose serum containing MTSD significantly down-regulated the gene and protein expressions of PCNA of HSC-T6 cells
and the differences between the treated cells and the controls were statistically significant (P0.05
P0.01
respectively). Conclusion The serum containing MTSD can significantly inhibit proliferation of HSC-T6 cells
induce cell apoptosis and down-regulate the PCNA expressions.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621